Conventional Treatment and its Effect on Survival of Malignant Pleural Mesothelioma in Western Australia
- 1 June 1982
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 12 (3) , 229-232
- https://doi.org/10.1111/j.1445-5994.1982.tb02466.x
Abstract
Analysis of the survival of all 81 cases of pathologically confirmed malignant pleural mesothelioma in Western Australia between Jan. 1957-Dec. 1980 revealed a median survival from diagnosis of 5.1 mo. (mean 7.8 mo). The average time between presentation and diagnosis was 3.4 mo. Survival was better in younger subjects and subjects selected for surgery but was unrelated to sex, symptoms at onset, history of asbestos exposure, tumor morphology, therapy other than surgery or year of presentation. The selection of subjects at earlier clinical stages for surgical intervention is considered to account for their longer survival. The outlook for patients with this disease remains poor; this is still no optimism for future advances in therapy.Keywords
This publication has 7 references indexed in Scilit:
- Malignant MesotheliomaNew England Journal of Medicine, 1980
- Multimodality therapy for malignant mesothelioma based on a study of natural historyThe American Journal of Medicine, 1980
- The value of adriamycin in the treatment of diffuse malignant pleural mesotheliomaCancer, 1978
- Pleural Mesothelioma: Clinical Features and Therapeutic ImplicationsAnnals of Internal Medicine, 1977
- Pleural mesotheliomaCancer, 1976
- Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.Thorax, 1976
- CLINICAL ASPECTS OF MESOTHELIOMA1976